«Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational study» – Observational Study – May 2022 – Roberto Lozano-Rodríguez 1 2, Verónica Terrón-Arcos 1 2, Karla Montalbán-Hernández 1 2, José Carlos Casalvilla-Dueñas 1 2, Marta Bergón-Gutierrez 1 2, Alejandro Pascual-Iglesias 1 2, Jaime Valentín Quiroga 1 2, Luis A Aguirre 1 2, Rebeca Pérez de Diego 1, Carmen Vela-Olmo 3, Lissette López-Morejón 3, Alejandro Martín-Quirós 4, Álvaro Del Balzo-Castillo 1 4, María A Peinado-Quesada 4, Miguel A García-Garrido 4, Laura Gómez-Lage 4, Carmen Herrero-Benito 4, Irene Llorente-Fernández 5, Gema Martín-Miguel 5, Margarita Torrejón 5, Carolina Cubillos-Zapata 6 7, Carlos Del Fresno 1 2, José Avendaño-Ortiz 1 2, Eduardo López-Collazo 1 2 7 No abstract available Read more Categorías: COVID-19, PublicationsPor Carlos del Fresnomayo 15, 2022Deja un comentarioNavegación entre publicacionesAnteriorPublicación anterior:Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung CancerSiguientePublicación siguiente:Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsRelated PostsEndotoxin tolerance and trained immunity: breaking down immunological memory barriersmayo 1, 2024Heat-killed Mycobacterium tuberculosis induces trained immunity in vitro and in vivo administered systemically or intranasallyenero 31, 2024Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lungoctubre 9, 2023mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individualsabril 24, 2023Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsjulio 1, 2022Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung Cancerabril 30, 2022
Heat-killed Mycobacterium tuberculosis induces trained immunity in vitro and in vivo administered systemically or intranasallyenero 31, 2024
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lungoctubre 9, 2023
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individualsabril 24, 2023
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsjulio 1, 2022
